Zobrazeno 1 - 10
of 28
pro vyhledávání: ''
Autor:
Rogelio Garcia Centeno, María Calatayud Gutiérrez, Felicia A. Hanzu, César Mínguez Ojeda, Mireia Mora, Oscar Vidal, Juan Carlos Percovich Hualpa, Ana Serrano Romero, Victoria Gómez Dos Santos, Mariana Tomé Fernández-Ladreda, Marta Araujo-Castro, María-Carmen López-García, Cristina Álvarez-Escolá, Paola Gracia Gimeno, Nuria Valdés, Cristina Lamas, Paz de Miguel Novoa, Concepción Blanco-Carrera
Publikováno v:
Endocrine-Related Cancer. 28:695-703
We aimed to identify presurgical and surgical risk factors for intraoperative complications in patients with pheochromocytomas. A retrospective study of patients with pheochromocytomas who underwent surgery in ten Spanish hospitals between 2011 and 2
Publikováno v:
Endocrine-Related Cancer; Mar2010, Vol. 17 Issue 1, p265-272, 8p
Publikováno v:
Endocrine-Related Cancer. 23:R71-R84
In differentiated thyroid carcinoma refractory to radioactive iodine (CDT-RTI), chemotherapy has been considered for decades to be the only systemic therapy with palliative purpose. Phase II studies assessing the efficacy of different chemotherapy ou
Autor:
Taesung Kim, Yuh-S. Jung, Jeyun Jang, Chang Hwan Ryu, Seok-Ki Kim, Daeyoon Park, Jin Soo Lee, Seok Yeon Park, Junsun Ryu, Jae-Goo Kang, Chang Yoon Lee, Eun Kyung Lee, You Jin Lee, Seung Myung Dong, Tae Hyun Kim
Publikováno v:
Endocrine-Related Cancer. 22:679-686
We undertook this study to estimate an accurate incidence and spread patterns of occult papillary thyroid carcinoma (PTC) in patients with a preoperative diagnosis of solitary PTC by using whole-specimen mapping of all specimens after a total thyroid
Autor:
Pascal Burtin, Julien Hadoux, Désirée Deandreis, Sophie Leboulleux, David Malka, Pierre Duvillard, Isabelle Borget, Michel Ducreux, J.-Y. Scoazec, Valérie Boige, Cecile N Chougnet, M. Schlumberger, Eric Baudin, Yohann Loriot, A. Berdelou, Caroline Caramella, Joël Guigay, David Planchard
Publikováno v:
Endocrine-Related Cancer. 22:289-298
There is no standard for second-line chemotherapy in poorly differentiated grade 3 neuroendocrine carcinoma (G3-NEC) patients. We analyzed the antitumor efficacy of 5-fluorouracil and oxaliplatin (FOLFOX) chemotherapy in this population. A single-cen
Autor:
Brenda Gumz, Kimberly Kamp, Gregory Kaltsas, Richard A Feelders, Dik Kwekkeboom, Frederico Costa, Wouter de Herder
Publikováno v:
Endocrine-Related Cancer, 20(6), 825-831. Bioscientifica Ltd
Although 177Lu-octreotate is an effective treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs), some patients will fail or develop disease progression necessitating further treatment. We examined whether the safety and
Publikováno v:
Endocrine-Related Cancer. 20:R291-R305
Paragangliomas (PGLs) are tumours originating from neural crest-derived cells situated in the region of the autonomic nervous system ganglia. Head-and-neck PGLs (HNPGLs) originate from the sympathetic and parasympathetic paraganglia, most frequently
Autor:
Jennifer A. Chan, Larry K. Kvols, Tiffany Campos, Matthew H. Kulke, Thomas A. Abrams, Jeffrey A. Meyerhardt, Jill Weber, Jonathan R. Strosberg, Eileen Regan, Charles S. Fuchs, Rachel Brady, David P. Ryan
Publikováno v:
Endocrine-Related Cancer. 20:383-390
The IGF pathway has been implicated in the regulation of neuroendocrine tumor (NET) growth, and preliminary studies suggested that ganitumab (AMG 479), a human MAB against IGF1R, may have antitumor activity in this setting. We performed a two-cohort
Publikováno v:
Bone Abstracts.
Autor:
Håkan Ahlman, Bengt E Nilsson, Anders Odén, C E Jakobsson, Svante Jansson, Bo Wängberg, Sven Lindstedt, Ola Nilsson, Amir Khorram-Manesh
Publikováno v:
Endocrine-Related Cancer. 17:265-272
Adrenocortical carcinoma (ACC) is a rare tumour disease with sinister prognosis also after attempts to radical surgery; better prognosis is seen for low-stage tumours. Adjuvant treatment with the adrenolytic drug mitotane has been attempted, but not